- Johnson Johnson: Changing health for humanity
Johnson Johnson MedTech innovates at the intersection of biology and technology With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases Healthcare areas include: Cardiovascular, Orthopaedics, Surgery and
- Our Credo and our purpose - Johnson Johnson
At Johnson Johnson, for more than 80 years, our commitment to helping people has been built into our Our Credo We blend heart, science and ingenuity to profoundly impact health for humanity
- Johnson Johnson Launches First and Only Daily Disposable Multifocal . . .
JACKSONVILLE, FL – June 23, 2025 – Today, Johnson Johnson, † a global leader in eye health, announced the launch of ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, the first and only daily disposable contact lens for people with both astigmatism and presbyopia 1 This pioneering contact lens provides patients crisp, clear, stable vision at all distances and in all lighting
- Johnson Johnson Reports Q4 and Full-Year 2024 Results
NEW BRUNSWICK, N J -- (BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024 "2024 was a transformative year for Johnson Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson “As a healthcare company
- Johnson Johnson Reports Q4 and Full-Year 2023 Results
NEW BRUNSWICK, N J -- (BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2023 “Johnson Johnson’s full year 2023 results reflect the breadth and competitiveness of our business and our relentless focus on delivering for patients,” said Joaquin Duato, Chairman and Chief Executive Officer “We have entered 2024 from a position of
- Multiple myeloma - innovativemedicine. jnj. com
Survival outcomes in multiple myeloma have significantly improved thanks to decades of treatment advances With more than half of the 11 innovative therapies approved for its treatment in the past two decades, Johnson Johnson has helped transform patients’ lives with numerous approved innovative treatments We aim to develop curative therapies, with urgency, and shifting the treatment
- MedTech - Johnson Johnson
Johnson Johnson MedTech innovates at the intersection of biology and technology
- Global Johnson Johnson websites
If you don’t see your country or region represented above, please click below to find links to the company’s Innovative Medicine and MedTech country and regional websites
|